[ad_1] CDSCO Panel Backs Label Change Allowing Endocrinologists, Rheumatologists to Prescribe Amgen’s Romosozumab We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Armed with positive results in two phase 3 trials, Takeda intends to file for approval of its oral psoriasis therapy zasocitinib in the US and other countries next year, with Bristol Myers Squibb’s Sotyktu in its sights. Once-daily zasocitinib, described as a second-generation TYK2 inhibitor, met all its safety and efficacy objectives in patients…
[ad_1] Biocon Biologics secures market entry date for Denosumab biosimilars in Europe, Rest of World We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. NEW ORLEANS — A cholesterol-lowering injection that’s been on the market for nearly a decade has now shown its power to cut cardiovascular events in people considered at high risk but…
[ad_1] AstraZeneca Tezspire approved in EU for chronic rhinosinusitis with nasal polyps We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. BERLIN — In June, Amgen reported that an experimental drug had hit the main goal of a gastric cancer study, improving overall survival in “a statistically significant and clinically meaningful” way. It said it would…
[ad_1] AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Biocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Amgen announces USD 650 million expansion of US manufacturing network We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link